CancerWorld shared a post on LinkedIn:
“Dr. Michael Gnant’s journey reflects a physician-scientist who has not only challenged conventional oncology practices but also helped shape how clinical research and care are understood and applied globally.
The profile features a clinician who has evolved from pushing boundaries to guiding them through international collaboration, mentorship, and a commitment to advancing evidence-based care.
Key topics of the article also include:
- Evidence-based treatment de-escalation and reducing unnecessary chemotherapy
- The evolving role of biomarkers such as circulating tumor DNA (ctDNA)
- Structural, funding, and regulatory challenges in European clinical research
- Patient-centered care and shared decision-making in an era of increasing complexity
- The cautious, responsible integration of artificial intelligence in clinical practice.
Dr. Michael Gnant’s work reflects a career defined by balance between innovation and restraint, between technological advancement and human connection. His perspective challenges the field to look beyond what medicine can do, and to focus on what it should do.
A legacy grounded in thoughtful progress: measured, global, and deeply patient-centered.
Read the full CancerWorld article by Yeva Margaryan, MD, MPH.”
Other articles featuring CancerWorld on OncoDaily.